Multivessel disease in primary percutaneous coronary intervention

Area of Science:

• Cardiology
• Interventional Cardiology
• Cardiovascular Disease

Background:

• Primary percutaneous coronary intervention (PCI) is the standard treatment for acute transmural myocardial infarction (AMI).
• Approximately 50% of AMI patients present with multivessel (MV) coronary artery disease.
• MV disease in AMI is linked to negative prognostic factors and increased long-term mortality.

Purpose of the Study:

• To review clinical data on the treatment of MV coronary artery disease diagnosed during primary PCI for AMI.
• To discuss the challenges in decision-making for treating non-culprit lesions in AMI.
• To summarize current understanding of early atherosclerosis progression post-AMI.

Main Methods:

• Review of available clinical data and studies.
• Analysis of prognostic factors associated with MV disease in AMI.
• Examination of short-term atherosclerosis progression after AMI.

Main Results:

• Multivessel coronary artery disease in AMI patients is associated with adverse cardiac events and increased mortality.
• Treatment of non-culprit lesions during primary PCI presents a complex clinical decision.
• Understanding of early atherosclerosis progression after AMI is crucial for management.

Conclusions:

• The management of multivessel coronary artery disease in the context of primary PCI for AMI requires careful consideration.
• Further research is needed to optimize treatment strategies for these complex patients.
• Addressing non-culprit lesions may impact long-term outcomes in AMI survivors.